Arm Holdings plc - American Depositary Shares (ARM)

Amazon's net margin expanded to 10.8% while Celsius surged 85.5% in revenue, but profitability tells a different story.

Ocugen (NASDAQ:OCGN) said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an RMAT designation for the program. Chairman, Chief Executive Officer and Co-Founder Shankar Musunuri sa

Intellia Therapeutics (NASDAQ:NTLA) said it advanced its lead gene-editing programs during the second quarter, highlighting positive Phase III results for lonvo-z in hereditary angioedema and the resumption of enrollment in Phase III studies of nex-z for transthyretin amyloidosis. Chief Executive O

Church & Dwight delivered a positive second quarter, with management highlighting broad-based organic sales growth across its divisions and strong consumer d...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Today, Aug. 6, 2026, software and cloud names tumbled as investors question valuations while geopolitical tensions added fresh headwinds.

Best PRP P-Shot Clinic in Dubai | Glamorous Clinic in DubaiMen’s wellness is an important part of confidence, comfort, and overall quality of life. With ad

Generate Biomedicines focuses on AI-enabled drug discovery.

Palantir, Microsoft, and ServiceNow look like potential big AI SaaS winners.

The company's 2018 decision to stop reporting unit sales in 2019 means investors aren't seeing the full bullish story. Fortunately, IDC is still keeping score.

They're competitors, but they're decreasingly alike. This is going to make a difference sooner or later.

Arm Holdings (ARM) stock surged over 11% on Tuesday after analysts highlighted 100%+ year-over-year data center royalty growth and strong AI chip demand.

Modern enterprise security teams face endless streams of network alerts every day. Organizations deploy a unified security platform to consolidate critical

A broader sell-off in AI stocks weighed on Arm.

Revenue hit $1.31 billion with strong international growth and margin expansion.

Uber and Lyft report earnings this week, but one ride-sharing giant stands out as the much stronger long-term buy.

The consensus bottom-line forecasts most investors were comparing its results to didn't appear to factor in changes stemming from a recent spinoff, or any one-time costs related to it.

Compugen (NASDAQ:CGEN) said its second-quarter 2026 progress included continued enrollment in its MAIA-ovarian study of COM701, advancing partner-led programs with AstraZeneca and Gilead, and a cash runway projected to extend into 2029. President and Chief Executive Officer Eran Ophir described the

The company is now more confident in hitting its near-term CPU target.

One builds the chips; the other licenses the blueprint. Their vastly different business models and risk profiles demand different investor strategies.

There just wasn't room for anything less than perfection. But, there's a "but."

Nano Nuclear Energy is riding a wave of good news.

Church & Dwight (NYSE:CHD) reported second-quarter results that exceeded its prior outlook, driven by broad-based volume growth, market-share gains and contributions from innovation. The company raised its full-year sales, earnings and cash-flow outlook despite what management described as a dynamic

Lam Research gets a nice chunk of its revenue from sales of memory manufacturing equipment, and that's great news for its future.

Arm delivered solid results, but all eyes are on its upcoming AGI CPU chip.